Menu

Kristin VanderPas' practice focuses on public and private security offerings. She has represented both issuers and investment banks in a variety of equity and debt transactions, including initial public offerings, secondary offerings of common stock and convertible note offerings. Kristin is also a market leader in SPAC M&A transactions, representing both target companies and investors in the de-SPAC process in transactions ranging in value up to $5 billion. Kristin also counsels clients in general corporate and securities law matters.

Download full bio 

Experience

  • LumiraDx Limited – $100.3 Million Follow-on Offering and Concurrent Private Placement 

  • Pliant Therapeutics – $230.0 Million Follow-on Offering 

  • Arcutis Biotherapeutics – $172.5 Million Follow-on Offering 

  • Crinetics Pharmaceuticals – $125 Million Follow-On Offering 

  • Zymeworks – $115 Million Follow-On Offering 

  • View all

Practices & Industries

Kristin VanderPas has a strong client base of leading investment banks and companies in the tech and life sciences sectors. – Chambers USA 2022
Education

  • University of Southern California Gould School of Law
    JD, 2009

  • University of North Carolina at Chapel Hill
    BSBA , Business Administration
    2006


Admissions & Credentials

California

Rankings & Accolades

    Chambers USA: Up and Coming – Capital Markets: Debt & Equity (California and Nationwide – Western United States) (2021-2022)

    Daily Journal: Top 40 Under 40 (2019)